Long-Term Follow-up of HIV Positive Asymptomatic Patients Having Received Cyclosporin A
The data of the 27 asymptomatic HIV-1 seropositive patients with CD4 + cell count between 300 and 600/µl treated by Cyclosporin A (CSA) (7.5 mg/kg/day) in our institution between october 1985 and 1987 were rewiewed in October 1993. Hemoglobin concentration, platelet count, total lymphocytes, CD4+ and CD8+ cell counts and serum core protein p24 antigenemia, as well as creatininemia measured before CSA onset, at CSA cessation and twice a year were recorded as well as clinical signs and CSA toxicities. In October 1993 median duration of CSA treatment was 11 months, median follow-up after CSA cessation was 45 months and median total follow-up was 67 months. Toxicities of CSA were those commonly encountered in other pathologies. Under CSA no patient progressed toward clinical AIDS (1987 definition). The mean CD4+ cell count of the 27 patients remained unchanged (gain of 1 cell/year) under CSA treatment, while it decreased at a rate of 50 cells/year after CSA cessation (p<0,005). On the other hand CSAtreatment had no significant impact on the evolution of total lymphocyte count, CD8+ cell counts, and P24 antigenémia.
KeywordsHuman Immunodeficiency Virus Human Immunodeficiency Virus Type Human Immunodeficiency Virus Disease Total Lymphocyte Count Immunosuppressive Drug Cyclosporin
Unable to display preview. Download preview PDF.
- 3.Andrieu JM, Even P, Tourani JM, Beldjord K, Audroin C. Results of a 2-year exploratory study with cyclosporin A in human immunodeficiency virus infection. Auto-immune aspects of HIV infection (JM Andrieu, JF Bach, P Even Eds). International congress and symposium series N 41, Royal Society of Medicine Services. London New-York 1988.Google Scholar
- 4.Aboulker JP, Andrieu JM, Gastaud JA et al. Two month double blind placebo controlled trial of cyclosporin in HIV asymptomatic subjects. V international conference on AIDS 1989; p402 (Abst).Google Scholar
- 13.Gougeon ML, Olivier R, Garcia S, Guetard D, Dragic T, Dauguet C, Montagnier L. Mise en évidence d’un processus d’engagement vers la mort cellulaire par apoptose dans les lymphocytes de patients infectés par le VIH. CR Acad Sci Paris 1991;312:529–537.Google Scholar
- 19.Schwarz A, Offerman G, Keller F, Bennhold I, L’Age Stehr J, Krause PH, Mihatsch MJ. The effect of cyclosporin on the progression of human imunodeficiency virus type 1 infection transmitted by transplatnation. Data on four cases and review of the literature. Transplantation 1993;55:95–103.PubMedCrossRefGoogle Scholar